Eli Lilly And reported $1.6B in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1277M 119M
Baxter International BAX:US 1.01B 18M
Biogen BIIB:US $ 375.3M 55.1M
Bristol Myers Squibb BMY:US $ 3609M 637M
Catalent CTLT:US $ 385M 19.3M
Coherus Biosciences CHRS:US $ 14.57M 0.91M
Drreddys Laboratories RDY:US $ 28607M 4863M
Eli Lilly And LLY:US $ 1597.8M 41.8M
Endo International Ordinary Shares ENDP:US $ 103.84M 0.68M
Horizon Pharma HZNP:US $ 51.95M 8.96M
Intercept Pharmaceuticals ICPT:US $ 15.09M 2.51M
JAZZ PHA JAZZ:US $ 64.83M 12.91M
Lannett LCI:US $ 29.58M 3.02M
Medtronic MDT:US $ 1864M 242M
Novartis NOVN:VX 4.81B 229M
Novartis NVS:US $ 4811M 229M
Perrigo Ordinary Shares PRGO:US $ 402.4M 27.9M
Phibro Animal Health PAHC:US $ 68.36M 5.56M
Prestige Brands PBH:US $ 30.96M 15.02M
Regeneron Pharmaceuticals REGN:US $ 476M 66.9M
Revance Therapeutics RVNC:US $ 8.18M 1.1M
Teva Pharmaceutical Industries TEVA:US $ 1551M 141M
Zoetis ZTS:US $ 369M 23M